HMP Stock Overview
Hemp & Health S.A. intends to cultivate, process, and distribute medical cannabis.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Hemp & Health S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | zł0.44 |
| 52 Week High | zł0.88 |
| 52 Week Low | zł0.12 |
| Beta | -1.67 |
| 1 Month Change | -15.61% |
| 3 Month Change | 47.32% |
| 1 Year Change | 233.71% |
| 3 Year Change | -62.54% |
| 5 Year Change | 377.77% |
| Change since IPO | -75.93% |
Recent News & Updates
Shareholder Returns
| HMP | PL Capital Markets | PL Market | |
|---|---|---|---|
| 7D | -5.8% | 3.3% | 2.3% |
| 1Y | 233.7% | 48.0% | 27.0% |
Return vs Industry: HMP exceeded the Polish Capital Markets industry which returned 38.2% over the past year.
Return vs Market: HMP exceeded the Polish Market which returned 27.3% over the past year.
Price Volatility
| HMP volatility | |
|---|---|
| HMP Average Weekly Movement | 24.5% |
| Capital Markets Industry Average Movement | 5.2% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in PL Market | 9.7% |
| 10% least volatile stocks in PL Market | 3.2% |
Stable Share Price: HMP's share price has been volatile over the past 3 months.
Volatility Over Time: HMP's weekly volatility has increased from 17% to 24% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 3 | Radomir Wozniak | www.hempandhealth.pl |
Hemp & Health S.A. intends to cultivate, process, and distribute medical cannabis. The company offers hemp flowers, isolates, distillates, and THC products. It also plans to sell private and white label formula products based on cannabinoids derived from hemp; and conducts research and development works for the uses of cannabis based on THC and CBD, and other cannabinoids.
Hemp & Health S.A. Fundamentals Summary
| HMP fundamental statistics | |
|---|---|
| Market cap | zł31.85m |
| Earnings (TTM) | -zł901.28k |
| Revenue (TTM) | zł271.51k |
117.3x
P/S Ratio-35.3x
P/E RatioIs HMP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HMP income statement (TTM) | |
|---|---|
| Revenue | zł271.51k |
| Cost of Revenue | zł299.07k |
| Gross Profit | -zł27.56k |
| Other Expenses | zł873.72k |
| Earnings | -zł901.28k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 15, 2024
| Earnings per share (EPS) | -0.012 |
| Gross Margin | -10.15% |
| Net Profit Margin | -331.95% |
| Debt/Equity Ratio | 0% |
How did HMP perform over the long term?
See historical performance and comparison